Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study
- DOI
- 10.1080/10428190290006035
- Published
- 2002-01
- Container
- Leukemia & Lymphoma
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/10428190290006035,
title = {Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study},
author = {Luisa Mantovani and Dirk Hasenclever and Rainer Krahl and Wolfram Pönisch and Michael Herold and Rita Pasold and Friedrich Fiedler and Gottfried Dölken and Dietrich Kämpfe and Hans Joachim Schmoll and Rita Súbert and Martin Kubel and Dietger Niederwieser and Werner Helbig},
year = {2002},
journal = {Leukemia \& Lymphoma},
doi = {10.1080/10428190290006035},
url = {https://doi.org/10.1080/10428190290006035}
}RIS
TY - JOUR TI - Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study AU - Luisa Mantovani AU - Dirk Hasenclever AU - Rainer Krahl AU - Wolfram Pönisch AU - Michael Herold AU - Rita Pasold AU - Friedrich Fiedler AU - Gottfried Dölken AU - Dietrich Kämpfe AU - Hans Joachim Schmoll AU - Rita Súbert AU - Martin Kubel AU - Dietger Niederwieser AU - Werner Helbig PY - 2002 JO - Leukemia & Lymphoma DO - 10.1080/10428190290006035 UR - https://doi.org/10.1080/10428190290006035 ER -
APA
Mantovani, L., Hasenclever, D., Krahl, R., Pönisch, W., Herold, M., Pasold, R., Fiedler, F., Dölken, G., Kämpfe, D., Schmoll, H. J., Súbert, R., Kubel, M., Niederwieser, D., & Helbig, W. (2002). Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study. Leukemia & Lymphoma. https://doi.org/10.1080/10428190290006035
Source records
- crossref · retrieved 2026-09-27T13:19:48.267Z